gip and glp 1 Mechanisms underlying GLP-1, GIP, DPP-4 glucose regulation Dual GIP/GLP-1 receptor agonists: New
Description
Initially, it was a modest tool in the diabetes arsenal: enhanced insulin release, suppressed glucagon, slowed gastric emptying
But we know that when you take them for years, if you have heart disease, that youre more likely to be alive than if you get a placebo instead
In addition, since the side effects involve pancreatic cancer, which has an extremely low survival rate, there have been wrongful death suits filed against the manufacturers
Stay persistent
